Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
Authors
Keywords
NMDA, Glutamate, Treatment-resistant depression, Major depressive disorder, Bipolar disorder, Antidepressant, Esketamine
Journal
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Volume 105, Issue -, Pages 110126
Publisher
Elsevier BV
Online
2020-10-06
DOI
10.1016/j.pnpbp.2020.110126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using early changes in cold cognition to predict response to vortioxetine in major depressive fisorder
- (2020) Caroline Park et al. PSYCHIATRY RESEARCH
- Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment
- (2020) Beata R. Godlewska et al. PSYCHOPHARMACOLOGY
- The Effectiveness of Ketamine on Anxiety, Irritability, and Agitation: Implications for Treating Mixed Features in Adults with Major Depressive or Bipolar Disorder
- (2020) Roger S. McIntyre et al. BIPOLAR DISORDERS
- The Effectiveness of Repeated Intravenous Ketamine on Depressive Symptoms, Suicidal Ideation and Functional Disability in Adults with Major Depressive Disorder and Bipolar Disorder: Results from the Canadian Rapid Treatment Center of Excellence
- (2020) Roger S McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
- (2019) Jennifer L. Phillips et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Predicting Antidepressant Response Using Early Changes in Cognition: A Systematic Review
- (2018) Caroline Park et al. BEHAVIOURAL BRAIN RESEARCH
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- Response rate profiles for major depressive disorder: Characterizing early response and longitudinal nonresponse
- (2018) Mary E. Kelley et al. DEPRESSION AND ANXIETY
- Impact of subjective vs. objective remission status on subjective cognitive impairments in depression
- (2018) Kyosuke Sawada et al. JOURNAL OF AFFECTIVE DISORDERS
- Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder
- (2017) Roger S. McIntyre et al. JOURNAL OF CLINICAL PSYCHIATRY
- Predicting Treatment Response in Major Depressive Disorder: The Impact of Early Symptomatic Improvement
- (2017) Paul A Kudlow et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
- (2016) Cristina Cusin et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Sidney H. Kennedy et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
- (2016) Chadi G. Abdallah et al. DEPRESSION AND ANXIETY
- Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the antidepressant effects of ketamine
- (2016) Roberto Cadeddu et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- The use of ketamine as an antidepressant: a systematic review and meta-analysis
- (2015) Caoimhe M. Coyle et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A neurocognitive model for understanding treatment action in depression
- (2015) Matthew B. Warren et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- (R,S)-Ketamine Metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine Increase the Mammalian Target of Rapamycin Function
- (2014) Rajib K. Paul et al. ANESTHESIOLOGY
- Early Switching Strategies in Antidepressant Non-Responders: Current Evidence and Future Research Directions
- (2014) Paul A. Kudlow et al. CNS DRUGS
- The role of mTOR in depression and antidepressant responses
- (2014) Helena M. Abelaira et al. LIFE SCIENCES
- What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
- (2014) Bradley N. Gaynes et al. PSYCHIATRIC SERVICES
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
- (2014) David A. Mrazek et al. PSYCHIATRIC SERVICES
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
- (2013) Paulo R. Shiroma et al. JOURNAL OF AFFECTIVE DISORDERS
- Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test
- (2012) Chun Yang et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Ketamine Inhibits Transcription Factors Activator Protein 1 and Nuclear Factor-κB, Interleukin-8 Production, as well as CD11b and CD16 Expression: Studies in Human Leukocytes and Leukocytic Cell Lines
- (2010) Ingeborg D. Welters et al. ANESTHESIA AND ANALGESIA
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder
- (2009) Armin Szegedi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Trajectories of change in depression severity during treatment with antidepressants
- (2009) R. Uher et al. PSYCHOLOGICAL MEDICINE
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now